Practice Management

Chasing the Sweet Spot: Managing Diabetes in the Modern Era

November 30, 2020

With the prevalence of diabetes continuing to grow, Gregory Weiss, MD, reflects on his experience treating patients with diabetes as a cardiologist and how recent advances have impacted cardiology.

Growing Pains: Perspective on Burnout and Changing Expectations in Medicine

November 29, 2020

Dr. Gregory Weiss details how the expectations of clinicians, and cardiologists specifically, has changed since he began practicing.

Does Fenofibrate Help or Hurt Renal Function?

November 27, 2020

Dr. Paul D. Thompson tackles the topic of whether use of fenofibrate helps or harms kidney function.

AliveCor's Kardia AI V2 Algorithm Suite Receives FDA Clearance

November 24, 2020

AliveCor announced the US FDA has granted 510(k) clearance to Kardia AI V2 algorithm suite.

Muthiah Vaduganathan, MD: Key Takeaways from Sotagliflozin Data

November 21, 2020

A cardiologist from Brigham and Women's Hospital offers his thoughts on the results of phase 3 SCORED and SOLOIST trials, which examined use of sotagliflozin in patients with type 2 diabetes.

Comparing Cost-Effectiveness of Antidiabetic Therapies with Cardiovascular Benefit

November 19, 2020

Gregory Weiss, MD, examines 4 studies presented at AHA Scientific Sessions 2020 comparing the cost-effectiveness of antidiabetic agents for reducing cardiovascular events.

AHA & AstraZeneca Push for Uptake of SGLT2 Inhibitors with TRANSLATE-HF Program

November 18, 2020

TRANSLATE-HF is a collaborative effort between the AHA and AstraZeneca with the goal of increasing and optimizing SGLT2 inhibitor use in US patients. Hear further insight lead author from the first of 6 TRANSLATE-HF studies, which was presented at AHA 2020.